HUE044292T2 - Eljárások és készítmények aeroszolok elõállítására - Google Patents
Eljárások és készítmények aeroszolok elõállításáraInfo
- Publication number
- HUE044292T2 HUE044292T2 HUE11705486A HUE044292T2 HU E044292 T2 HUE044292 T2 HU E044292T2 HU E11705486 A HUE11705486 A HU E11705486A HU E044292 T2 HUE044292 T2 HU E044292T2
- Authority
- HU
- Hungary
- Prior art keywords
- aerosols
- compositions
- preparation
- methods
- Prior art date
Links
- 239000000443 aerosol Substances 0.000 title 1
- 239000000203 mixture Substances 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/12—Aerosols; Foams
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/0078—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a nebulizer such as a jet nebulizer, ultrasonic nebulizer, e.g. in the form of aqueous drug solutions or dispersions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
- C07K16/10—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from RNA viruses
- C07K16/1027—Paramyxoviridae, e.g. respiratory syncytial virus
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pulmonology (AREA)
- Dispersion Chemistry (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Molecular Biology (AREA)
- Virology (AREA)
- Organic Chemistry (AREA)
- Biochemistry (AREA)
- Otolaryngology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Oncology (AREA)
- Immunology (AREA)
- Communicable Diseases (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US30344710P | 2010-02-11 | 2010-02-11 | |
US201061426610P | 2010-12-23 | 2010-12-23 |
Publications (1)
Publication Number | Publication Date |
---|---|
HUE044292T2 true HUE044292T2 (hu) | 2019-10-28 |
Family
ID=43899571
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HUE11705486 HUE044292T2 (hu) | 2010-02-11 | 2011-02-11 | Eljárások és készítmények aeroszolok elõállítására |
Country Status (17)
Country | Link |
---|---|
US (3) | US9713589B2 (hu) |
EP (2) | EP2533761B1 (hu) |
JP (3) | JP5951508B2 (hu) |
CN (2) | CN102753148B (hu) |
AU (1) | AU2011214299B2 (hu) |
CA (1) | CA2787718C (hu) |
CY (1) | CY1122634T1 (hu) |
DK (1) | DK2533761T3 (hu) |
ES (2) | ES2931330T3 (hu) |
HK (1) | HK1222128A1 (hu) |
HR (1) | HRP20191071T1 (hu) |
HU (1) | HUE044292T2 (hu) |
LT (1) | LT2533761T (hu) |
PL (2) | PL2533761T3 (hu) |
PT (2) | PT2533761T (hu) |
SI (1) | SI2533761T1 (hu) |
WO (1) | WO2011098552A2 (hu) |
Families Citing this family (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA3004707C (en) | 2009-09-02 | 2022-05-31 | Synedgen Inc. | Methods and compositions for disrupting biofilm utilizing chitosan-derivative compounds |
EP2533761B1 (en) | 2010-02-11 | 2019-03-27 | Ablynx N.V. | Methods and compositions for the preparation of aerosols |
MY163995A (en) | 2010-03-12 | 2017-11-15 | Berg Llc | Intravenous formulations of coenzyme q10 (coq10) and methods of use thereof |
MX369543B (es) * | 2011-06-17 | 2019-11-12 | Berg Llc | Composiciones farmaceuticas inhalables. |
US20150216977A1 (en) * | 2012-09-18 | 2015-08-06 | Adocia | Stable pharmaceutical composition, comprising an aqueous solution of an antibody-derived therapeutically active protein |
JP6603207B2 (ja) | 2013-03-15 | 2019-11-06 | ボード・オブ・リージエンツ,ザ・ユニバーシテイ・オブ・テキサス・システム | ヌトリン3aおよびペプチドを用いた肺線維症の阻害 |
NL1040254C2 (en) * | 2013-05-17 | 2014-11-24 | Ablynx Nv | Stable formulations of immunoglobulin single variable domains and uses thereof. |
CN115177588A (zh) * | 2014-04-03 | 2022-10-14 | 瑞士杰特贝林生物制品有限公司 | 免疫球蛋白的雾化 |
KR20170094121A (ko) * | 2014-09-11 | 2017-08-17 | 시너드젠, 인크. | 조성물 및 그의 사용 방법 |
SG11201702688UA (en) * | 2014-10-10 | 2017-04-27 | Ablynx Nv | Methods of treating rsv infections |
TR201909589T4 (tr) * | 2014-10-10 | 2019-07-22 | Ablynx Nv | Solunum hastalıklarının aerosol terapisinde kullanıma yönelik inhalasyon cihazı. |
AU2016225111B2 (en) * | 2015-02-27 | 2021-12-09 | Board Of Regents, The University Of Texas System | Polypeptide therapeutics and uses thereof |
CA3022697A1 (en) | 2016-05-02 | 2017-11-09 | Ablynx Nv | Treatment of rsv infection |
WO2018099968A1 (en) | 2016-11-29 | 2018-06-07 | Ablynx N.V. | Treatment of infection by respiratory syncytial virus (rsv) |
WO2018220234A1 (en) | 2017-06-02 | 2018-12-06 | Merck Patent Gmbh | Adamts binding immunoglobulins |
CA3111563A1 (en) | 2018-09-10 | 2020-03-19 | Lung Therapeutics, Inc. | Modified peptide fragments of cav-1 protein and the use thereof in the treatment of fibrosis |
Family Cites Families (62)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2052027T5 (es) | 1988-11-11 | 2005-04-16 | Medical Research Council | Clonacion de secuencias de dominio variable de inmunoglobulina. |
US5945098A (en) * | 1990-02-01 | 1999-08-31 | Baxter International Inc. | Stable intravenously-administrable immune globulin preparation |
US5938117A (en) | 1991-04-24 | 1999-08-17 | Aerogen, Inc. | Methods and apparatus for dispensing liquids as an atomized spray |
ES2322324T3 (es) | 1992-08-21 | 2009-06-19 | Vrije Universiteit Brussel | Inmumoglobulinas desprovistas de cadenas ligeras. |
AU6796094A (en) | 1993-04-29 | 1994-11-21 | Raymond Hamers | Production of antibodies or (functionalized) fragments thereof derived from heavy chain immunoglobulins of (camelidae) |
FR2708622B1 (fr) | 1993-08-02 | 1997-04-18 | Raymond Hamers | Vecteur recombinant contenant une séquence d'un gène de lipoprotéine de structure pour l'expression de séquences de nucléotides. |
US5758637A (en) | 1995-08-31 | 1998-06-02 | Aerogen, Inc. | Liquid dispensing apparatus and methods |
US6085740A (en) | 1996-02-21 | 2000-07-11 | Aerogen, Inc. | Liquid dispensing apparatus and methods |
US5586550A (en) | 1995-08-31 | 1996-12-24 | Fluid Propulsion Technologies, Inc. | Apparatus and methods for the delivery of therapeutic liquids to the respiratory system |
US6205999B1 (en) | 1995-04-05 | 2001-03-27 | Aerogen, Inc. | Methods and apparatus for storing chemical compounds in a portable inhaler |
US6014970A (en) | 1998-06-11 | 2000-01-18 | Aerogen, Inc. | Methods and apparatus for storing chemical compounds in a portable inhaler |
EP0739981A1 (en) | 1995-04-25 | 1996-10-30 | Vrije Universiteit Brussel | Variable fragments of immunoglobulins - use for therapeutic or veterinary purposes |
AU740043B2 (en) | 1996-06-27 | 2001-10-25 | Vlaams Interuniversitair Instituut Voor Biotechnologie Vzw | Recognition molecules interacting specifically with the active site or cleft of a target molecule |
EP1027439B1 (en) | 1997-10-27 | 2010-03-17 | Bac Ip B.V. | Multivalent antigen-binding proteins |
WO1999037681A2 (en) | 1998-01-26 | 1999-07-29 | Unilever Plc | Method for producing antibody fragments |
AU3041100A (en) | 1999-01-05 | 2000-07-24 | Unilever Plc | Binding of antibody fragments to solid supports |
ATE276359T1 (de) | 1999-01-19 | 2004-10-15 | Unilever Nv | Verfahren zur herstellung von antikörperfragmenten |
EP1169453A1 (en) | 1999-04-22 | 2002-01-09 | Unilever Plc | Inhibition of viral infection using monovalent antigen-binding proteins |
US6479280B1 (en) | 1999-09-24 | 2002-11-12 | Vlaams Interuniversitair Institutuut Voor Biotechnologie Vzw | Recombinant phages capable of entering host cells via specific interaction with an artificial receptor |
PT1233987E (pt) | 1999-11-29 | 2009-12-28 | Bac Ip B V | Imobilização de moléculas de ligação ao antigénio de um domínio |
US7358096B1 (en) | 1999-11-29 | 2008-04-15 | Conopco, Inc. | Immobilisation of proteins |
EP1134231B1 (en) | 2000-03-14 | 2009-04-15 | Unilever N.V. | Antibody heavy chain variable domains against human dietary lipases, and their uses |
AU2001268855A1 (en) | 2000-05-26 | 2001-12-03 | National Research Council Of Canada | Single-domain antigen-binding antibody fragments derived from llama antibodies |
US20040053340A1 (en) | 2000-12-13 | 2004-03-18 | De Haard Johannes Joseph | Protein arrays |
US20060073141A1 (en) | 2001-06-28 | 2006-04-06 | Domantis Limited | Compositions and methods for treating inflammatory disorders |
JP4213586B2 (ja) | 2001-09-13 | 2009-01-21 | 株式会社抗体研究所 | ラクダ抗体ライブラリーの作製方法 |
JP2005289809A (ja) | 2001-10-24 | 2005-10-20 | Vlaams Interuniversitair Inst Voor Biotechnologie Vzw (Vib Vzw) | 突然変異重鎖抗体 |
EP1456410A2 (en) | 2001-12-11 | 2004-09-15 | AlgoNomics N.V. | Method for displaying loops from immunoglobulin domains in different contexts |
US20050037358A1 (en) | 2001-12-21 | 2005-02-17 | Serge Muyldermans | Method for cloning of variable domain sequences |
JP2005517674A (ja) | 2002-01-03 | 2005-06-16 | フラームス・インテルウニフェルシタイル・インステイチュート・フォール・ビオテヒノロヒー・ヴェーゼットウェー | 腫瘍の処置に有用な新規免疫コンジュゲート |
US20050271660A1 (en) | 2002-09-06 | 2005-12-08 | Alexion Pharmaceuticals, Inc. | Nebulization of monoclonal antibodies for treating pulmonary diseases |
EP1558650A2 (en) | 2002-11-08 | 2005-08-03 | Ablynx N.V. | Camelidae antibodies against immunoglobulin e and use thereof for the treatment of allergic disorders |
WO2004041862A2 (en) | 2002-11-08 | 2004-05-21 | Ablynx N.V. | Single domain antibodies directed against tumour necrosis factor-alpha and uses therefor |
WO2005044858A1 (en) | 2003-11-07 | 2005-05-19 | Ablynx N.V. | Camelidae single domain antibodies vhh directed against epidermal growth factor receptor and uses therefor |
ES2542330T3 (es) | 2003-01-10 | 2015-08-04 | Ablynx N.V. | Polipéptidos terapéuticos, homólogos de los mismos, fragmentos de los mismos y su uso en modular la agregación mediada por plaquetas |
US7461263B2 (en) | 2003-01-23 | 2008-12-02 | Unspam, Llc. | Method and apparatus for a non-revealing do-not-contact list system |
CA2535550A1 (en) | 2003-08-12 | 2005-03-03 | William M. Yarbrough | Treatment for acne vulgaris and method of use |
US7563443B2 (en) | 2004-09-17 | 2009-07-21 | Domantis Limited | Monovalent anti-CD40L antibody polypeptides and compositions thereof |
BRPI0518151A2 (pt) | 2004-10-13 | 2009-06-16 | Ablynx Nv | polipetìdeos contra amiloide-beta, ácido nucléico que codifica tal polipetìdeo, composição compreendendo tal polipetìdeo, método para produzir um polipetìdeo e uso do mesmo |
EP1844073A1 (en) | 2005-01-31 | 2007-10-17 | Ablynx N.V. | Method for generating variable domain sequences of heavy chain antibodies |
EP2479191A3 (en) | 2005-05-18 | 2013-03-13 | Ablynx N.V. | Improved nanobodiesTM against tumor necrosis factor-alpha |
ES2852423T3 (es) | 2005-05-20 | 2021-09-13 | Ablynx Nv | NanobodiesTM mejorados para el tratamiento de trastornos mediados por agregación |
WO2009074634A2 (en) | 2007-12-13 | 2009-06-18 | Glaxo Group Limited | Compositions for pulmonary delivery |
JP2009523459A (ja) * | 2006-01-24 | 2009-06-25 | ドマンティス リミテッド | 天然の連結部を含有する融合タンパク質 |
AU2007224631A1 (en) | 2006-03-13 | 2007-09-20 | Ablynx N.V. | Amino acid sequences directed against IL-6 and polypeptides comprising the same for the treatment of diseases and disorders associated with IL-6-mediated signalling |
CA2666599A1 (en) | 2006-08-18 | 2008-02-21 | Ablynx N.V. | Amino acid sequences directed against il-6r and polypeptides comprising the same for the treatment of diseases and disorders associated with il-6-mediated signalling |
EP2069402A2 (en) | 2006-09-08 | 2009-06-17 | Ablynx N.V. | Serum albumin binding proteins with long half-lives |
CA2667466A1 (en) | 2006-10-27 | 2008-05-02 | Ablynx N.V. | Intranasal delivery of polypeptides and proteins |
CA2672595A1 (en) | 2006-12-15 | 2008-06-19 | Guy Hermans | Amino acid sequences that modulate the interaction between cells of the immune system |
US20100062004A1 (en) | 2006-12-19 | 2010-03-11 | Ablynx N.V. | Amino acid sequences directed against gpcrs and polypeptides comprising the same for the treatment of gpcr-related diseases and disorders |
US9156914B2 (en) | 2006-12-19 | 2015-10-13 | Ablynx N.V. | Amino acid sequences directed against a metalloproteinase from the ADAM family and polypeptides comprising the same for the treatment of ADAM-related diseases and disorders |
US20100166734A1 (en) | 2006-12-20 | 2010-07-01 | Edward Dolk | Oral delivery of polypeptides |
EP2097451A2 (en) | 2006-12-22 | 2009-09-09 | Ablynx N.V. | Anti-chemokine (ccl2, ccl3, ccl5, cxcl11, cxcl12) single-domain antibodies |
BRPI0806313A2 (pt) * | 2007-01-09 | 2011-09-06 | Wyeth Corp | Formulação de anticorpo anti-il-13; formulação em aerossol de um anticorpo anti-il-13; formulaçãoliofilizada de um anticorpo anti-il-13; composição farmacêutica para o tratamento de um transtorno relacionado a il-13; fabricação de uma composição farmacêutica ; método de tratamento de um transtorno relacionado a il-13; seringa injetável; dispositivo para administração nasal; emplastro transdérmico; bolsa intravenosa; kit compreendendo pelo menos um recipiente; kit; e seringa injetável previamente enchida |
CA2678218A1 (en) | 2007-02-21 | 2008-08-28 | Ablynx N.V. | Amino acid sequences directed against vascular endothelial growth factor and polypeptides comprising the same for the treatment of conditions and diseases characterized by excessive and/or pathological angiogenesis or neovascularization |
AU2008252854A1 (en) | 2007-05-24 | 2008-11-27 | Ablynx N.V. | Amino acid sequences directed against growth factor receptors and polypeptides comprising the same for the treatment of diseases and disorders associated with growth factors and their receptors |
CA2687903C (en) | 2007-05-24 | 2016-09-13 | Ablynx N.V. | Amino acid sequences directed against rank-l and polypeptides comprising the same for the treatment of bone diseases and disorders |
AU2008328779B2 (en) | 2007-11-27 | 2014-06-05 | Ablynx N.V. | Amino acid sequences directed against HER2 and polypeptides comprising the same for the treatment of cancers and/or tumors |
HUE042053T2 (hu) | 2008-06-05 | 2019-06-28 | Ablynx Nv | Vírus burokfehérjéi elleni aminosav-szekvenciák és az azokat tartalmazó polipeptidek virális betegségek kezelésére |
BRPI1010830A2 (pt) | 2009-06-05 | 2023-11-14 | Ablynx Nv | Sequências de aminoácidos melhoradas direcionadas contra o vírus respiratório sencicial humano (hrsv) e polipetídeos que compreende os mesmos para prevenção e/ou tratamento de infecções do trato respiratório. |
EP2473527B1 (en) | 2009-09-03 | 2016-11-30 | Ablynx N.V. | Stable formulations of polypeptides and uses thereof |
EP2533761B1 (en) | 2010-02-11 | 2019-03-27 | Ablynx N.V. | Methods and compositions for the preparation of aerosols |
-
2011
- 2011-02-11 EP EP11705486.6A patent/EP2533761B1/en active Active
- 2011-02-11 CN CN201180009097.7A patent/CN102753148B/zh active Active
- 2011-02-11 SI SI201131740T patent/SI2533761T1/sl unknown
- 2011-02-11 HU HUE11705486 patent/HUE044292T2/hu unknown
- 2011-02-11 WO PCT/EP2011/052024 patent/WO2011098552A2/en active Application Filing
- 2011-02-11 CN CN201510824525.1A patent/CN105380904A/zh active Pending
- 2011-02-11 PL PL11705486T patent/PL2533761T3/pl unknown
- 2011-02-11 JP JP2012552404A patent/JP5951508B2/ja active Active
- 2011-02-11 PL PL19152522.9T patent/PL3501499T3/pl unknown
- 2011-02-11 DK DK11705486.6T patent/DK2533761T3/da active
- 2011-02-11 AU AU2011214299A patent/AU2011214299B2/en active Active
- 2011-02-11 PT PT11705486T patent/PT2533761T/pt unknown
- 2011-02-11 US US13/577,961 patent/US9713589B2/en active Active
- 2011-02-11 LT LTEP11705486.6T patent/LT2533761T/lt unknown
- 2011-02-11 CA CA2787718A patent/CA2787718C/en active Active
- 2011-02-11 ES ES19152522T patent/ES2931330T3/es active Active
- 2011-02-11 EP EP19152522.9A patent/EP3501499B1/en active Active
- 2011-02-11 PT PT191525229T patent/PT3501499T/pt unknown
- 2011-02-11 ES ES11705486T patent/ES2738114T3/es active Active
-
2016
- 2016-06-08 JP JP2016114294A patent/JP6283064B2/ja active Active
- 2016-08-31 HK HK16110367.6A patent/HK1222128A1/zh unknown
-
2017
- 2017-04-24 US US15/495,199 patent/US11007146B2/en active Active
-
2018
- 2018-01-25 JP JP2018010149A patent/JP7019433B2/ja active Active
-
2019
- 2019-06-13 HR HRP20191071TT patent/HRP20191071T1/hr unknown
- 2019-06-26 CY CY20191100668T patent/CY1122634T1/el unknown
-
2021
- 2021-04-19 US US17/233,621 patent/US20210346287A1/en active Pending
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1222128A1 (zh) | 用於製備氣霧劑的方法和組合物 | |
IL263729A (en) | Preparations and methods for removing biofilms | |
HK1202071A1 (en) | Biocidal compositions and methods of using the same | |
HK1185796A1 (zh) | 包含近端支化化合物的組合物及其製備方法 | |
ZA201402734B (en) | Collector compositions and methods of using the same | |
EP2536756A4 (en) | HSA-RELATED COMPOSITIONS AND USE PROCESSES | |
EP2584897A4 (en) | COMPOSITIONS CONTAINING RESVERATROL AND METHODS OF USE | |
EP2569425A4 (en) | ENDORIBONUCLEASE COMPOSITIONS AND METHOD FOR THEIR USE | |
IL222969A0 (en) | Sweetener compositions and methods of preparing the same | |
GB2507210B (en) | Insecticidal compositions and methods of using the same | |
EP2596112A4 (en) | ACETYCYSTEIN COMPOSITIONS AND USE METHOD THEREFOR | |
EP2582664A4 (en) | PHENYL THIOACETATE COMPOUNDS AND COMPOSITIONS AND METHOD FOR THEIR USE | |
EP2629742A4 (en) | HAIR CARE COMPOSITIONS AND RELATED METHODS | |
EP2552202A4 (en) | METHODS AND COMPOSITIONS FOR WEIGHT LOSS | |
EP2539444A4 (en) | COMPOSITIONS AND METHODS FOR THE PRODUCTION OF L-HOMOALANINE | |
HK1189501A1 (zh) | 抗體組合物及使用方法 | |
EP2633047A4 (en) | COMPOSITIONS AND METHOD FOR PRODUCING BLOOD PLATES AND USE METHOD THEREFOR | |
HK1201451A1 (en) | Compositions and methods | |
GB201018650D0 (en) | Methods and compositions | |
HK1254904B (zh) | 用於改變xlhed表型的組合物和方法 | |
IL226174A0 (en) | Impulse preparations and methods for their preparation | |
GB201020357D0 (en) | Compounds and methods of making the same | |
GB201002278D0 (en) | composition and method of preparation | |
ZA201209495B (en) | Novel methods for the preparation of p2x7r antagonists | |
HU1000328D0 (en) | Nanostuctured indometachine compositions and process for their preparation |